Intravenous Infusions Plc (GHSE:IIL)
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Intravenous Infusions Market Cap
Intravenous Infusions has a market cap or net worth of 156.41 million as of November 17, 2026. It is the 39,440th most valuable company in the world and the 22nd biggest in Ghana. Its market cap has increased by 1,040.00% in one year.
Market Cap
156.41M
Enterprise Value
165.41M
Revenue
6.51M
Global Rank
Country Rank
#22 Ghana
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2015, Intravenous Infusions's market cap has increased from 18.13M to 156.41M, an increase of 762.75%. That is a compound annual growth rate of 21.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 156.41M | 1,040.00% |
| Dec 4, 2025 | 13.72M | - |
| Dec 22, 2023 | 13.72M | 6.02% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GOIL Plc | 2.04B |
| Fan Milk | 1.51B |
| Enterprise Group | 1.44B |
| Cocoa Processing Company | 1.41B |
| SIC Insurance | 880.40M |
| Clydestone Ghana | 122.06M |
| Dannex Ayrton Starwin | 93.24M |
| Hords | 70.12M |